ClinicalTrials.gg
RecruitingNCT07274124Updated Oct 9, 2026

Pain Neuroscience Education and Vagus Nerve Stimulation on Recovery in Individuals With Rheumatoid Arthritis

An interventional study of Pain Neuroscience Education and Vagal Nerve Stimulation in Rheumatic Diseases and Rheumatoid Arthritis (RA), sponsored by Medipol University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Primary conditionArthritis, RheumatoidRegistry: Rheumatic DiseasesReclassifiedWhy we changed it
Registry
Rheumatic Diseases — the first condition term the registry derived for this study.
ClinicalTrials.gg
Arthritis, Rheumatoid
Why
  1. The study's listed conditions name Arthritis, Rheumatoid, a narrower term within Rheumatic Diseases.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Medipol University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Updated Oct 9, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
20 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 128 studies in Arthritis, Rheumatoid with a site in Turkey — 14 open to participants now, 19 under way, 2 of them phase 3. Arthritis, Rheumatoid · Turkey.

Planned enrollment
62nd of 78
42 · median 77
Started
2026
with 5 others
No phase
44 of 128
5 open now
Primary completion
2027-05
later than 15 of 18 live
Registered
113th of 128
by date

Among the 128 studies in Arthritis, Rheumatoid with a site in Turkey, this one is the 62nd largest by planned enrollment of the 78 interventional ones that give a count, is one of 6 that started in 2026, is one of 44 with no phase, reaches primary completion later than 15 of the 18 other live ones, and was the 113th registered.

Arthritis, Rheumatoid

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

Browse Arthritis, Rheumatoid studies →

Open to participants now

14 of the 128 studies in Arthritis, Rheumatoid with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.

This study: 20 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 128 studies in Arthritis, Rheumatoid with a site in Turkey, or all of them as a file.
02

Study summary

In the context of this randomized controlled study, patients who are diagnosed with Rheumatoid arthritis in Cerrahpaşa Faculty of Medicine Hospital, will be taken into a rehabilitation program by a qualified physiotherapist to improve their pain, pain perception, inflammatory markers and quality of life, with one of the pain neuroscience education, vagal nerve stimulation and traditional exercise interventions. The results of each intervention method will be analyzed and compared at the end of the 8 weeks study protocol.

Read the detailed description

Pain, a complex and multifaceted experience, is the most common symptom observed in inflammatory arthritis. In addition to pathological events such as inflammation and tissue infection, various personal, social, and behavioral factors such as illness beliefs, mood, behavior, avoidance, sleep disturbance, and daily rest and activity status also contribute to pain and pain perception. According to the 2018 EULAR recommendations, the principles of pain management methods are based on a patient-centered care and social assistance models of rehabilitation. According to PNE, the primary cause of chronic pain is not an organ or tissue damage, but rather over activation of the central nervous system and central sensitization and the goal is to reduce CNS activation, minimize fear of movement, and increase pain tolerance, thereby supporting exercise participation. Based on the biopsychosocial model, this method aims to reduce movement and illness avoidance behavior by reshaping pain perception. It is typically presented to patients through one-on-one or group meetings, phone calls, or visual brochures. Another effective method on the indicated pain related symptoms is known as Vagal nerve stimulation. Neural regulation can be achieved by vagal nerve stimulation, which is related to the pain-processing pathways of the brain, or pain reduction can be achieved indirectly through the anti-inflammatory effect it creates. While studies in the literature on VNS mostly focus on individuals with chronic pain, fibromyalgia, abdominal pain, and headache, there are few studies on rheumatoid arthritis. Besides no studies have examined the effects of PNE. This research points to a significant deficiency in pain perception, awareness, and control in individuals with RA. Based on this information, the aim of this study was to examine the effects of pain neuroscience training and vagal nerve stimulation on healing parameters in individuals with rheumatoid arthritis and to compare the results in terms of their superiority.

03

Conditions studied

  • Rheumatic Diseases
  • Rheumatoid Arthritis (RA)

Browse trials for

Keywords

  • rheumatoid arthritis
  • pain neuroscience education
  • vagal nerve stimulation
  • exercise
04

In context

Arthritis, Rheumatoid Reclassified

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

This study's planned enrollment of 42 is below the median of 96 across 2,226 interventional studies indexed under Arthritis, Rheumatoid.

Browse Arthritis, Rheumatoid studies →

Lead sponsor

Medipol University is the lead sponsor of 328 studies on the registry; 86 are open to participants now.

Compared within Arthritis, Rheumatoid, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Rheumatic Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

The criteria were revised on the registry on Oct 9, 2026. See what changed

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals who were diagnosed with RA at least one year ago,
  • More than score 2.6 in DAS28,
  • Ages of 20 and 65,
  • Have been experiencing pain for three months or more,
  • Score 24 or higher on the (MMSE), and can follow instructions will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Individuals under 20 years of age,
  • Reporting acute pain or pain from injury,
  • Having a history of surgery within the last year,
  • Remission in DAS28,
  • Patients whose medication was changed,
  • Having a score of \<24 on the ,
  • Having any of the cerebrovascular disease, cardiovascular disease, symptomatic coronary artery disease, myocardial infarction, congestive heart failure, or uncontrolled hyper/hypotension,
  • History of vagotomy surgery, or having an implanted electrical/neurostimulator device will not be included in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Pain Neuroscience Education + Structured Exercise

    The PNE method will be applied simultaneously with exercise. Training will begin after the first session, which includes a face-to-face assessment. On the first day, a PowerPoint presentation will introduce the patient about pain anatomy, physiology, factors affecting pain, and central and peripheral sensitization. The topic of pain will be introduced, and the patient will be informed about the process. Pain mechanisms will be reviewed using video explanations, visual aids, and animations, information will be provided on what physical activity is and its effects on pain, patients will be asked their opinions on exercise, suggestions for physical daily, living activities will be given such as increasing activity, using stairs, limiting screen time type of suggestions will be thought to the patient and the patient's wishes and goals will be questioned in the further sessions. Each session will last 30 minutes and 16 education sessions will be completed in total.

    Other: Pain Neuroscience Education · Other: Structured Exercises

  • Experimental
    Vagal Nerve Stimulation + Structured Exercise

    Will be applied with the non-invasive taVNS-Research (tVNS®) device, which is the only safe auricular vagus stimulation device approved by the Ministry of Health in Türkiye and is used in various diseases such as headache, epilepsy, and fibromyalgia. Electrodes will be placed on the left auricular cavum conchae using two carbon-impregnated silicone electrodes to reduce the risk of cardiac side effects. Vagal nerve stimulation will be administered twice a week for 8 weeks, with a total of 16 supervised sessions. During this period, the home exercise intervention that patients are asked to perform will continue. Following the initial evaluation, the exercises will be taught to the patient, and the first nerve stimulation session will be performed. Current intensity will be adjusted according to the patient tolerance-threshold value, and this value will be recorded for each session.

    Other: Vagal Nerve Stimulation · Other: Structured Exercises

  • Active comparator
    Structured Exercise

    The Structured exercise intervention, specifically for individuals with RA and designed to target painful areas, will be implemented in the form of home exercises for all three groups, twice a week for 8 weeks. The exercise program will primarily consist of warm-up, basic exercise, and a cool-down period. Aerobic, strengthening, flexibility, breathing, and hand exercises will be planned based on EULAR recommendations. The warm-up period will begin with flexibility and range of motion exercises, followed by calisthenic and therapeutic endurance and strengthening exercises, and the session will ended with diaphragmatic breathing and hand exercises during the cool-down period. Additionally, walking activity will be recommended for at least two days per week.

    Other: Structured Exercises

Interventions

  • OtherPain Neuroscience Education

    Many sources in the literature draw attention to patient education as the first stage of treatment and the most common educational technique that focuses on the perception, mechanism and modulation of pain is known as Pain Neuroscience Education (PNE). Patients in this group will take educational sessions about the pain, facilitators of pain, the factors affecting the pain perception and how to deal with chronic pain in rheumatoid arthritis with the help of power point presentations, animation videos, pictures and drawings. Intervention will last for 8 weeks, 2 times per week, in total 16 sessions will be completed. Each session will last 30 minutes in average and at the same time, patients will be advised to perform the given home exercises for 2 times per week. Assessments will be performed before and after the intervention.

  • OtherVagal Nerve Stimulation

    Vagus nerve (cranial nerve X) is the longest and most widely distributed cranial nerve containing sensory, motor, and parasympathetic fibers. It plays an important role in the regulation of cardiovascular, respiratory, immune, endocrine, and autonomic systems, as well as homeostasis. Participants with rheumatoid arthritis will be taken into stimulation sessions for 2 times per week for continuous 8 weeks. Assessments will be performed before study and after the 16 sessions are completed. Since the literature has missing knowledge about the effects of Vagal nerve stimulation in rheumatoid arthritis, the results will highlight the effects on pain and inflammatory markers in this population. Current will be given from the left ear/transauricular area to prevent the side effects in the sessions.

  • OtherStructured Exercises

    Structured exercise planned in this study is based on the principles and suggestions of EULAR, by consisting warm-up, basic exercise and warm up sessions by combining different exercise types like aerobic, strengthening flexibility, breathing and definitely by including hand specific exercises. Participants in all three groups will be educated in the first session about the exercises to prevent wrong application and injuries. Afterwards, all groups will continue to their exercises at the home setting. An exercise diary will be asked from patients to control if they continue to their exercises regularly for 2 times for 8 weeks.

07

What researchers measure

Primary outcomes

  1. Pain Catastrophizing Scale

    13-item questionnaire, based on personal feedback, assesses the severity of patients' reactions to pain on a scale of 0-4. The validity and reliability of the questionnaire in Turkish has been established.

    Time frame: 8 weeks

  2. Disease Activity Score-28 (DAS28)

    Assesses disease activity in 28 different joints. Blood draws will be performed by a specialist physician who diagnoses patients, conducts regular checkups, and then refers suitable patients to a physical therapist. A score below 2.6 indicates the disease is in remission; scores between 2.6 and 3.1 indicate low disease activity; scores between 3.1 and 5.1 indicate moderate disease activity; and scores above 5.1 indicate high disease activity.

    Time frame: 8 weeks

Secondary outcomes

  1. Demographic Information Form

    The patient's personal information, medical treatment history, current lifestyle, and exercise habits will be inquired about using a form specifically designed for the specific disease.

    Time frame: At the beginning only

  2. Mcgill Pain Questionnaire Short Form

    Developed by Melzack in 1987, the questionnaire assesses chronic pain in three sections: pain characteristics, severity, and intensity, has also been validated in Turkish and is recommended for use in rheumatological patients. The Turkish validation of the questionnaire was conducted by Yavuz et al. in 2007, and it was found to be valid in Turkish. Higher score indicates severe pain severity.

    Time frame: 8 weeks

  3. Pain Algometry

    The pressure pain threshold (PPT), defined as the minimum pressure stimulus applied to elicit pain, is suitable for measuring pain in RA. Pain thresholds will be measured using an algometer at the third metacarpophalangeal (MCP) joints, the wrist, and the most inflamed joints.

    Time frame: 8 weeks

  4. Pain Coping Inventory

    Indicates how frequently patients use behavioral and cognitive methods to cope with pain. The questionnaire, consisting of 6 subscales (active and passive), inquires about patients' orientations during painful situations. Items are scored on a 4-point Likert scale, with 1 being the least frequent use of pain management measures and 4 being the most frequent.

    Time frame: 8 weeks

  5. Tampa Kinesiophobia Scale

    Published in 1995 to measure fear of movement and re-injury, the questionnaire consists of 17 items. Questions address areas such as fear of re-injury and avoidance of movement. A score of 17 is the lowest possible score, and indicates no kinesiophobia or negligible.

    Time frame: 8 weeks

  6. Bristol Rheumatoid Arthritis Multidimensional Fatigue Questionnaire

    Examines the various dimensions of the effects of RA on fatigue. It was developed in 2010. The questionnaire consists of four subcategories: physical fatigue in the last 7 days, fatigue in activities of daily living, and cognitive and emotional fatigue. Patients receive scores between 0 and 70 on the 20-question questionnaire, with higher scores indicating higher fatigue.

    Time frame: 8 weeks

  7. Pittsburgh Sleep Quality Scale

    19-item scale questions subjective sleep quality over the past month. The total score ranges from 0 to 21, with a higher score indicating poor sleep quality. A Turkish version of the scale is available and is used in rheumatological diseases.

    Time frame: 8 weeks

  8. Rheumatoid Arthritis Quality of Life Scale

    30-item scale, with valid and reliable Turkish versions, is a published quality of life questionnaire specific to rheumatoid arthritis. Higher scores indicate lower quality of life.

    Time frame: 8 weeks

  9. Community Integration Scale-Revised

    (CIQ-R) is a brief, standardized instrument used to assess community integration in individuals following neurological conditions. The scale consists of 14 items organized into a four-factor structure, including home integration, social integration, productive activities, and communication/electronic social networking. It evaluates participants' level of independence and engagement in daily life over the past month, with higher scores indicating greater community participation. Findings from validation studies demonstrate that the Turkish version of the CIQ-R is a valid and reliable tool for assessing community integration in individuals with stroke. The availability of this instrument supports its use in clinical practice, outcome assessment, and cross-cultural research in stroke rehabilitation.

    Time frame: 8 weeks

  10. Upper and Lower Extremity Goniometry and Circumference Measurements

    To examine the relationship between pain and joint range of motion, goniometry measurements will be taken at the four most commonly affected areas: the atlantoaxial joint, shoulder joint, wrist joint, and ankle with the degree of movement. Circumference measurements will be taken at the hand, finger, and ankle to assess inflammation in the centimeter measures.

    Time frame: 8 weeks

  11. Multiple Choice Questions and Answers

    Participants in the PNE group will be asked to answer 10 multiple-choice questions covering the presentation topics. This will provide information about the level of understanding of the information presented within the PNE group and its impact on the pain questionnaires, according to the score they take out of the total score of 100.

    Time frame: 8 weeks

08

Study locations

1 of 1 sites recruiting
  • Cerrahpaşa Faculty of Medicine Hospital
    Istanbul, Fatih, Turkey (Türkiye)
    Recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for May 2027, 15 months after the start.

Of 293 non-industry interventional studies with no phase under Arthritis, Rheumatoid, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 39. This study's planned 15 months is below that.

Counting every sponsor, half of 349 studies reached it within 27 months; a quarter within 13 and three quarters within 47.

Start moved once since we started tracking on Sep 25, 2026: Jan 2026 → Feb 2026, on Oct 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2025
First posted
Dec 10, 2025
StartActual
Feb 18, 2026was Jan 2026
Primary completionEst.
May 2027
CompletionEst.
Jul 2027
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 9, 2026
Sites
Cerrahpaşa Faculty of Medicine Hospital is now Recruiting
Oct 9, 2026
Start date
Jan 2026→Feb 18, 2026 (actual)
Oct 9, 2026
Enrollment
36→42
Oct 9, 2026
Eligibility
Minimum age 18 Years→20 Years; 1 inclusion criterion edited, 1 added; 1 exclusion criterion edited, 2 added
What changed in the criteria
Inclusion criteria
  • AddedMore than score 2.6 in DAS28,
  • EditedAges of 1820 and 65,
Exclusion criteria
  • EditedIndividuals under 1820 years of age,
  • AddedRemission in DAS28,
  • AddedPatients whose medication was changed,
Oct 9, 2026
Secondary outcomes
1 added
What changed in the outcomes
  • AddedCommunity Integration Scale-RevisedTime frame: 8 weeks
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Not yet recruiting→Recruiting
    Cerrahpaşa Faculty of Medicine Hospital is now Recruiting
    Start date Jan 2026→Feb 18, 2026 (now actual)
    Enrollment 36→42
    Eligibility Minimum age 18 Years→20 Years; 1 inclusion criterion edited, 1 added; 1 exclusion criterion edited, 2 added
    What changed in the criteria
    Inclusion criteria
    • AddedMore than score 2.6 in DAS28,
    • EditedAges of 1820 and 65,
    Exclusion criteria
    • EditedIndividuals under 1820 years of age,
    • AddedRemission in DAS28,
    • AddedPatients whose medication was changed,
    Secondary outcomes 1 added
    What changed in the outcomes
    • AddedCommunity Integration Scale-RevisedTime frame: 8 weeks
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07274124
Lead sponsor
Medipol University
Responsible party
Simay Akdemir (MSc. Phd Candidate, Lecturer Physical Therapist, Medipol University) — Principal investigator
First posted
Dec 10, 2025
Start date
Feb 18, 2026
Primary completion
May 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Oct 9, 2026

Study contacts

Simay AKDEMİR, MSc. Phd Candidate/Lec.
Contact
simay.akdemir@medipol.edu.tr
+905347032126
Ela TARAKCI, Prof. Dr.
Contact
etarakci@iuc.edu.tr
+905422175730
Simay AKDEMİR, MSc. Phd Candidate/Lec.
principal investigator · İstanbul University-Cerrahpaşa

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion